| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.423 | 16.576 | 18.106 | 21.415 | 27.256 | 28.807 | 29.098 | 33.259 | 46.933 | 53.125 |
| Total Income - EUR | 16.434 | 16.579 | 18.106 | 21.415 | 27.256 | 28.807 | 29.098 | 33.259 | 46.934 | 53.126 |
| Total Expenses - EUR | 10.820 | 11.620 | 13.914 | 13.870 | 21.110 | 17.987 | 22.556 | 19.425 | 23.362 | 32.561 |
| Gross Profit/Loss - EUR | 5.614 | 4.959 | 4.192 | 7.545 | 6.146 | 10.821 | 6.542 | 13.834 | 23.571 | 20.565 |
| Net Profit/Loss - EUR | 5.121 | 4.767 | 4.011 | 7.331 | 5.873 | 10.533 | 6.251 | 13.501 | 23.102 | 18.972 |
| Employees | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 2 | 3 |
Check the financial reports for the company - Romagmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 15.343 | 20.974 | 22.308 | 23.980 | 25.097 | 28.372 | 24.421 | 32.157 | 28.674 | 34.437 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.246 | 1.513 | 1.377 | 1.716 | 2.360 | 2.328 | 2.484 | 2.823 | 19.812 | 93 |
| Cash | 14.097 | 19.461 | 20.932 | 22.264 | 22.737 | 26.044 | 21.938 | 29.334 | 8.862 | 34.344 |
| Shareholders Funds | 12.037 | 16.681 | 15.724 | 18.829 | 17.149 | 21.981 | 22.489 | 29.977 | 23.150 | 31.303 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.349 | 4.293 | 6.584 | 5.151 | 7.948 | 6.390 | 1.932 | 2.180 | 5.523 | 3.134 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Romagmed Srl